Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Clinical trial NCT06126731 · RECRUITING
Trial details
- NCT number
- NCT06126731
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-02
- Primary completion
- 2026-06-30
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.